Drug recall · May 15, 2013
Liothyronine Sodium Tablets recall
Why: Failed Impurities/Degradation Specifications: 3 month stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,
- Lots / codes
12K714 exp. 12/13, 12K715 exp. 12/13
- Quantity
- 21,667 bottles
- Company
- L. Perrigo Co., Allegan, MI
- Distribution
- Nationwide
- Initiated
- March 12, 2013 · Voluntary: Firm initiated
- Classified
- May 9, 2013
- Reported
- May 15, 2013
- Ended
- July 24, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Liothyronine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.